These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31902260)

  • 1. Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational study.
    Alba P; Moreno V; Arias-Irigoyen J; Antón M; Parra A; Gómez-Fernández MC; Madariaga B; Martínez A; Begoña L
    Immunotherapy; 2020 Jan; 12(1):75-87. PubMed ID: 31902260
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and Effectiveness of a Single Multiallergen Subcutaneous Immunotherapy in Polyallergic Patients.
    Nevot-Falcó S; Mancebo EG; Martorell A; Calatayud CM; Perotti SC; Rojas MJ; Rodriguez-Rodriguez M; Padial MA; El Qutob Lopez FD; Perez-Camo I; Gomez-Brenosa B; Cano MDMG; Gonzalez de Olano D; Ferre-Ybarz L; López FF; Lara Jiménez Á; Aldunate-Muruzabal T; Pascual MC; Villas F; Garcia EC; Reche M; Antolin-Amerigo D; Barbarroja-Escudero J; Romero EN; Ruiz-Garcia M
    Int Arch Allergy Immunol; 2021; 182(12):1226-1230. PubMed ID: 34392241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum treatment strategies for polyallergic patients - analysis of a large observational trial.
    Shah-Hosseini K; Mioc K; Hadler M; Karagiannis E; Mösges R
    Curr Med Res Opin; 2015 Dec; 31(12):2249-59. PubMed ID: 26366617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
    Eberle P; Brueck H; Gall R; Hadler M; Sieber J; Karagiannis E
    Pediatr Allergy Immunol; 2014 Dec; 25(8):760-6. PubMed ID: 25378225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
    Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
    J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients.
    Pfaar O; Sager A; Robinson DS
    Pediatr Allergy Immunol; 2015 May; 26(3):280-286. PubMed ID: 25640879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children.
    Del-Río Camacho G; Montes Arjona AM; Fernández-Cantalejo Padial J; Rodríguez Catalán J
    Allergol Immunopathol (Madr); 2018; 46(6):552-556. PubMed ID: 30017214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy: Treating with Fewer Allergens?
    Damask C
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1153-1165. PubMed ID: 28964528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of treatment with 5-grass pollen tablets in patients with allergic rhinitis: a real-life study.
    Ras L; de Groot H; Stengs CH; van Weissenbruch R
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):52-58.e2. PubMed ID: 26596408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN; Galip N; Cobanoglu N
    Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real-life clinical study.
    Irani C; Saleh RA; Jammal M; Haddad F
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):802-7. PubMed ID: 25224283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.
    Roxbury CR; Lin SY
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1111-1119. PubMed ID: 28964530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated Dose Escalation with Three Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of Six Grasses Is Safe for Patients with Moderate to Severe Allergic Rhinitis.
    Kopp MV; Bovermann X; Klimek L
    Int Arch Allergy Immunol; 2020; 181(2):94-102. PubMed ID: 31865326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis.
    Gerstlauer M; Szepfalusi Z; Golden D; Geng B; de Blic J
    Ann Allergy Asthma Immunol; 2019 Jul; 123(1):70-80. PubMed ID: 31009701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and surrogate efficacy parameters of a polymerized depot mixture pollen extracts without dilutional effect.
    Quiralte J; Lara MA; Sánchez GV; Monteserín J; Fernández L; Gómez-Fernández MC; Madariaga B; Arilla C; Asturias JA; Begoña L; Martínez A
    Immunotherapy; 2019 Aug; 11(12):1031-1042. PubMed ID: 31234665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.